Centocor, Inc.
Patent Owner
Stats
- 70 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 29, 2013 most recent publication
Details
- 70 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 6,020 Total Citation Count
- May 07, 1982 Earliest Filing
- 144 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8361474 Anti-IL-12 antibody based vectors, host cells, and methods of production and usesApr 13, 10Jan 29, 13[A61K, C07H, C12P, C12N]
8277809 CXCL13 antagonists and their use for the treatment of inflammatory diseasesApr 20, 07Oct 02, 12[A61K]
8071103 Pharmaceutical composition comprising a human GLP-1 mimetibodyJul 18, 07Dec 06, 11[A61K, C07K]
8067191 Method for detecting IL-16 activity and modulation of IL-16 activity based on rantes proxy protein levelsJun 06, 07Nov 29, 11[A61K, C12N, G01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0052,066 MARKERS AND METHODS FOR ASSESSING AND TREATING LUPUS PATIENTS SUSCEPTIBLE TO PHOTOPROVOCATIONAbandonedNov 06, 09Mar 01, 12[A61K, C12Q, G01N, A61P, C40B]
7744885 Methods of treating vascular inflammatory pathology using anti-TNF antibodies and fragments thereofExpiredDec 07, 07Jun 29, 10[A61K, C07K]
2010/0074,901 HUMAN ANTI-AMYLOID ANTIBODIES, COMPOSITIONS, METHODS AND USESAbandonedOct 15, 08Mar 25, 10[A61K, C07H, C12P, C12N, G01N, C07K]
2010/0034,819 HUMAN EPO MIMETIC HINGE CORE MIMETIBODIES, COMPOSITIONS, METHODS AND USES FOR PREVENTING OR TREATING GLUCOSE INTOLERANCE RELATED CONDITIONS ON RENAL DISEASE ASSOCIATED ANEMIAAbandonedMar 30, 07Feb 11, 10[A61K, C12N]
2010/0028,904 WAY TO OBTAIN HIGH EXPRESSION CLONES OF MAMMALIAN CELLS USING A METHYLCELLULOSE WITH FLUORESCENT PROTEIN A OR G AND FLUORESCENT SCREENING METHODAbandonedMar 28, 08Feb 04, 10[C12Q, C12N, G01N]
2009/0325,873 HUMAN GLP-1 MIMETIBODIES, COMPOSITIONS, METHODS AND USESAbandonedJul 18, 07Dec 31, 09[A61K, C07H, C12Q, C12P, C12N, A61P, C07K]
2009/0214,528 HOST CELL LINES FOR PRODUCTION OF ANTIBODY CONSTANT REGION WITH ENHANCED EFFECTOR FUNCTIONAbandonedAug 31, 06Aug 27, 09[A61K, C12P, C12N, C07K]
2009/0136,509 Use of Toll-Like Receptor 4 Antagonists for the Treatment or Prevention of Osteoarthritic ConditionsAbandonedOct 31, 08May 28, 09[A61K]
2009/0041,762 Methods of treating ankylosing spondylitis using anti-TNF antibodies and peptides of human tumor necrosis factorAbandonedDec 13, 05Feb 12, 09[A61K, C12P]
2008/0311,034 Anti-Tissue Factor Antibodies and Compositions with Enhanced Effector FunctionAbandonedApr 28, 08Dec 18, 08[A61K, C07H, C12N, A01K, A61P, C07K]
7425330 Methods of inhibiting TNF.alpha. activity in the blood of a patientExpiredOct 16, 06Sep 16, 08[A61K]
7416729 Methods of treating rheumatoid arthritis with anti-TNF antibodiesExpiredJun 18, 07Aug 26, 08[A61K]
7404955 Methods of inhibiting or neutralizing TNF.alpha. in patients with tissue injuryExpiredAug 02, 05Jul 29, 08[A61K]
2008/0044,420 Anti-IL-13 antibodies, compositions, methods and usesAbandonedMay 10, 06Feb 21, 08[A61K, C12P, C12N, A01K, G01N, A61P, C07K, A61M]
2007/0298,040 Methods of treating seronegative arthropathy with anti-TNF antibodiesAbandonedApr 10, 06Dec 27, 07[A61K]
2007/0203,064 TLR3 Glycosylation Site Muteins and Methods of UseAbandonedOct 30, 06Aug 30, 07[A61K, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
